Loading organizations...
§ Private Profile · Eugene, OR, USA
Biotechnology developer providing environmental viral surveillance and patented COVID testing kits for facilities.
Based in Eugene, Oregon, Enviral Tech is a biotechnology company that develops environmental viral surveillance solutions, specifically providing patented surface and air testing kits for SARS-CoV-2 detection. The enterprise supplies these diagnostic tools and related services to various institutional clients, primarily serving long-term care facilities, public schools, commercial properties, and corporate offices. Operating with approximately 25 employees, the firm has processed over 20,000 surface tests across more than 100 facilities nationwide while generating under $5 million in annual revenue. To support its viral hygiene operations, Enviral Tech has secured $2.22 million in total financing through multiple equity and debt rounds, which includes a $1.5 million seed round in November 2020 and a subsequent $220,000 debt allocation. The biotechnology organization was officially founded in March 2020 by Shula Jaron, Brian Patch, and Stephen Turner.
Enviral Tech has raised $2.0M across 1 funding round.
Enviral Tech has raised $2.0M in total across 1 funding round.
Enviral Tech has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in October 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2020 | $2M Seed | Rogue Venture Partners | Cascade Seed Fund, Cascade | Announced |
Enviral Tech is a biotechnology company specializing in environmental viral surveillance solutions for buildings, primarily through patented surface and air testing for early COVID-19 detection.[1][2] It serves facilities like long-term care centers, schools, offices, and communities by providing molecular hygiene testing that delivers results within 24 hours, helping prevent infections, ensure safety, and boost business confidence.[1][4][6] Founded in March 2020 amid the pandemic, the company has processed over 20,000 surface tests across more than 100 U.S. facilities, operates from Eugene, Oregon, with about 25 employees, and has secured under $5 million in funding.[1]
The company solves the problem of undetected viral spread in shared spaces by acting as "viral sleuths," detecting pathogens in environments where people work and live, with an initial focus on SARS-CoV-2.[1][5] Its growth momentum includes rapid scaling during the pandemic's peak, launching state-of-the-art testing in August 2020, and targeting high-risk sectors like senior living and education.[4][6]
Enviral Tech was founded in March 2020 by scientists committed to infection control and making advanced detection technologies accessible.[1][3] The idea emerged during the early COVID-19 outbreak, leveraging expertise in biotechnology to address urgent needs for environmental monitoring in buildings, starting with patented surface and air testing kits.[1][2]
Early traction came quickly: by mid-2020, the company launched its SARS-CoV-2 Surface Check and Air Check services, processing thousands of tests nationwide and gaining adoption in over 100 facilities.[1][4] A pivotal moment was its August 2020 PR announcement highlighting 24-hour turnaround times tailored for vulnerable settings like long-term care and schools, establishing credibility in pandemic response.[4][6]
Enviral Tech rides the trend of environmental pathogen surveillance, accelerated by COVID-19, aligning with the rise of biotech tools for public health infrastructure.[1][2] Timing was critical: launching in 2020 positioned it as a rapid responder when surface transmission fears drove demand for non-invasive monitoring in high-risk buildings like schools and care facilities.[4][6]
Market forces favoring it include ongoing needs for hybrid work safety, aging populations requiring infection control in senior living, and regulatory pushes for hygiene tech post-pandemic.[3][5][6] It influences the ecosystem by pioneering scalable, building-level viral detection, potentially expanding to other pathogens and inspiring similar surveillance startups in biotech.[1]
Enviral Tech's next phase likely involves diversifying beyond COVID-19 to multi-pathogen detection, capitalizing on its patented tech for flu, RSV, or emerging threats in a world of recurring outbreaks.[1][2] Trends like AI-enhanced surveillance, climate-driven disease spread, and workplace wellness mandates will shape its path, with potential for partnerships in smart buildings or global expansion.[5]
Its influence may evolve from pandemic niche player to standard in facility hygiene, especially if funding grows beyond the initial <$5M to fuel R&D—watch for broader adoption in 2026 amid renewed health vigilance.[1] This positions Enviral Tech as a resilient biotech innovator, directly addressing the core challenge of invisible environmental risks in communal spaces.
Enviral Tech has raised $2.0M in total across 1 funding round.
Enviral Tech's investors include Rogue Venture Partners, Cascade Seed Fund, Cascade.